Detalhe da pesquisa
1.
Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19.
N Engl J Med;
385(13): 1184-1195, 2021 09 23.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34347950
2.
Effect of Subcutaneous Casirivimab and Imdevimab Antibody Combination vs Placebo on Development of Symptomatic COVID-19 in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
JAMA;
327(5): 432-441, 2022 02 01.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35029629
3.
Implementation of Molecular Surveillance After a Cluster of Fatal Toxoplasmosis at 2 Neighboring Transplant Centers.
Clin Infect Dis;
63(4): 565-8, 2016 08 15.
Artigo
em Inglês
| MEDLINE
| ID: mdl-27199460
4.
A Prospective Study of Key Correlates for Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2.
Open Forum Infect Dis;
10(7): ofad271, 2023 Jul.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37416758
5.
Nasopharyngeal Viral Load Is the Major Driver of Incident Antibody Immune Response to SARS-CoV-2 Infection.
Open Forum Infect Dis;
10(12): ofad598, 2023 Dec.
Artigo
em Inglês
| MEDLINE
| ID: mdl-38111750
6.
Examining protective effects of SARS-CoV-2 neutralizing antibodies after vaccination or monoclonal antibody administration.
Nat Commun;
14(1): 3605, 2023 06 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37330602
7.
Repeat subcutaneous administration of casirivimab and imdevimab in adults is well-tolerated and prevents the occurrence of COVID-19.
Int J Infect Dis;
122: 585-592, 2022 Sep.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35788416
8.
Efficacy and safety of a single dose of casirivimab and imdevimab for the prevention of COVID-19 over an 8-month period: a randomised, double-blind, placebo-controlled trial.
Lancet Infect Dis;
22(10): 1444-1454, 2022 10.
Artigo
em Inglês
| MEDLINE
| ID: mdl-35803290
9.
Subcutaneous REGEN-COV Antibody Combination in Early Asymptomatic SARS-CoV-2 Infection: A Randomized Clinical Trial.
medRxiv;
2021 Sep 18.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34159343
10.
Subcutaneous REGEN-COV Antibody Combination for Covid-19 Prevention.
medRxiv;
2021 Jun 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-34159344
11.
Urinary biomarkers of mycobacterial load and treatment response in pulmonary tuberculosis.
JCI Insight;
5(18)2020 09 17.
Artigo
em Inglês
| MEDLINE
| ID: mdl-32809976
12.
Mass Spectrometric Identification of Urinary Biomarkers of Pulmonary Tuberculosis.
EBioMedicine;
31: 157-165, 2018 May.
Artigo
em Inglês
| MEDLINE
| ID: mdl-29752217